US provides Ebola treatment for outbreak in Congo, bringing trials closer

Live updates

1. 1d ago

   Ebola Treatment Trials Begin in Democratic Republic of Congo

   Researchers started a study on Thursday to test two potential Ebola treatments in eastern Congo. The effort aims to improve survival rates as the outbreak grows. The World Health Organization is overseeing the clinical testing of these antiviral therapies.

   What's confirmed:

   • Researchers began a study of two possible Ebola treatments on Thursday in eastern Congo.
   • The World Health Organization announced the start of clinical testing for two antiviral therapy approaches.
   • There are 438 deaths linked to the outbreak.

   Still unconfirmed:

   • The Bundibugyo virus caused over 1,400 infections.
   • There are 1,406 confirmed cases and 301 suspected cases of the disease in DRC.
   confidence 90%
2. 6d ago

   US Provides Experimental Ebola Treatment for Congo Outbreak Trials

   The United States has supplied doses of an experimental antibody drug from Mapp Biopharmaceutical for clinical trials in the Democratic Republic of Congo. This move supports efforts to combat a widening Ebola outbreak. The WHO indicates that trials for two drugs are scheduled to begin next week.

   What's confirmed:

   • The US provided doses of an experimental antibody drug from Mapp Biopharmaceutical for clinical trials in the Democratic Republic of Congo.
   • The US previously stated the antibody drug would be available only to Americans deemed to be at high risk.
   • HHS sent the drug for the Ebola clinical trial.
   • The WHO chief stated that antivirals from Mapp and Gilead will be deployed in the DRC Ebola trial.

   Still unconfirmed:

   • The Ebola outbreak in the Democratic Republic of Congo has caused more than 1,000 deaths.
   • Trials of two Ebola treatments will start in the DRC next week.
   confidence 95%